12 articles · Updated · The New York Times · Apr 30
He died on Wednesday in San Diego, after recent hospitalisation for side effects from cancer treatment, the J. Craig Venter Institute said.
In 2000, his company Celera and a rival public effort jointly announced they had assembled the first human genomes, a milestone for genetics research.
A combative entrepreneur-scientist, Venter challenged the $3bn Human Genome Project with faster methods and helped drive repeated breakthroughs in the early genomics era.
How will Venter's final AI venture, Diploid Genomics, shape medicine without its founder's guidance?
Was Venter a scientific hero who accelerated progress or a profiteer who gambled with humanity’s code?
Beyond the human genome, what was the most significant discovery from Venter’s global ocean expeditions?
With AI now decoding DNA, are we finally realizing Venter’s vision of biology as programmable software?
How did Venter's experience as a Vietnam War corpsman influence his race to decode human life?
What does the continued work of Venter's key partner, Nobelist Hamilton Smith, reveal about their shared vision?